It has now been established that the offending post had
It has now been established that the offending post had lies in it -- fabricating material and claiming it was in a company filing, and claiming that the company was due to file a 10-K 3 months earlier than it actually is due.
The CEO of the company has stated that its ability to tap the Aspire financing is unchanged.
Any further lies about this will be DELETED.
Anyone who ever again posts material from this proven liar and claims that he is "reputable" will find their post deleted.
UNTRUTH IS A TERMS OF SERVICE VIOLATION HERE.
3
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
IntelAgree Recognized for Innovation in CLM IntelAgree, a leading player in contract lifecycle management (CLM) powered by artificial intelligence, has recently been honored as an 'Advanced Solution' in a distinguished analysis by The Hackett Group. This recognition solidifies IntelAgree’s reputation as a top platform in the business sector. Importance of The Hackett...
Continue Reading
Emergency Health Professionals Unite with Teamsters Local 120 Recently, a remarkable development unfolded as a dedicated group of 15 paramedics, EMTs, and emergency health professionals came together to join Teamsters Local 120. This resolute decision signifies their commitment to securing better working conditions and fair compensation. The Journey Toward Unionization...
Continue Reading
MSI Unveils Future-Proof Cloud Solutions At CloudFest 2025, MSI, a leader in high-performance server solutions, introduced its innovative next-generation server platforms, including the ORv3 Servers, DC-MHS Servers, and NVIDIA MGX™ AI Servers. This significant event showcased MSI's commitment to enhancing cloud infrastructure with a focus on scalability, performance,...
Continue Reading
St. Cloud Capital's Growth Capital Investment St. Cloud Capital has proudly announced a significant investment in Integrated Diagnostic Services (IDS). This initiative focuses on expanding their capabilities in mobile radiology and laboratory services. The investment aims to support IDS in acquiring Core Analytics Lab & Radiology, a leading provider in California....
Continue Reading
LeMaitre Vascular Shows Robust Growth in Q3 2024 BURLINGTON, Mass. – LeMaitre Vascular, Inc. (NASDAQ: LMAT), a leading provider of vascular devices and services, has reported exceptional results for the third quarter of 2024. The company’s strong performance demonstrates its commitment to innovation in the medical device sector, especially in the area of vascular...
Continue Reading
